ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs, and provides comprehensive resources to support pharmacy professionals through every stage of their careers.
Episodes
Tuesday Feb 23, 2021
Tuesday Feb 23, 2021
MCM COVID-19 Presentation: Roadmap to a COVID-19 Vaccine: Clinical Considerations for Ensuring Safety and Efficacy Part 1Vaccine Clinical Trial Design and Vaccine Development During a Pandemic
In this presentation from the 2020 Midyear Clinical Meeting, content matter experts describe clinical trial designs for COVID-19 vaccine candidates, identify important documentation requirements and safety surveillance measures and actions, outline opportunities to address vaccine hesitancy, calculate the number needed to vaccinate to stop widespread community transmission of SARS CoV-2 and discuss clinical implications related to COVID-19 vaccine(s) made available through Emergency Use Authorization.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Feb 22, 2021
Monday Feb 22, 2021
In today's episode, we take listeners on a deeper dive of specific details of FDA Emergency Use Authorizations: what they are, what they are not, how they are determined, specific nuances that they may subsequently enact, and how they are determined for approval. The topic is intended to be general around EUA’s, but COVID-19 specific examples are highlighted as well as those that have brought public attention to the EUA process.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Feb 18, 2021
Thursday Feb 18, 2021
This two-part podcast series provides listeners with a review of updates to the diabetes treatment guidelines. Speakers share an overview of guideline updates, evaluate treatment options, and discuss methods of addressing issues related to affordability and access to medications.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Tuesday Feb 16, 2021
Tuesday Feb 16, 2021
In this interprofessional conversation, expert faculty discuss the clinical effects of neuromuscular blocking and reversal agents, including key components of NMB and reversal strategies during the intraoperative phase of care and neuromuscular monitoring. Patient risk factors and mitigation of post-operative complications will also be discussed.
To learn more about neuromuscular blockade and reversal visit www.ashpadvantage.com/nmbreversal/
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Feb 11, 2021
Thursday Feb 11, 2021
February 7-14 is the Congenital Heart Defects (CHD) Awareness Week. Join members of ASHP’s Pediatric Section Advisory Group as they discuss CHD, the care of children and adults with CHD, the role of pharmacists in the care of patients with CHD, and general clinical pearls for caring for these patients.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Feb 10, 2021
Wednesday Feb 10, 2021
Front-line informatics pharmacists and health-system IT leaders share COVID-19 Emergency Use Authorization treatments and vaccines informatics pearls. Topics discussed will include standard IT and operational procedures for EUAs, EHR and infusion pump builds, compliance and documentation, and their tips on preparing for the next wave of EUAs.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Wednesday Feb 10, 2021
Wednesday Feb 10, 2021
In this ASHP podcast, student members discuss ASHP’s Experiential Education program and dive into the ins and outs of an APPE rotation in association management. ASHP Pharmacy Student Forum Advisory Group members Rachael Crusius and Zach Krauss, engage with past ASHP externs about their virtual or in-person experiences and talk about how this rotation helped them to grow both professionally and personally in their pharmacy journey.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Monday Feb 08, 2021
Monday Feb 08, 2021
The COVID-19 pandemic has caused changes in all practice settings of healthcare. The ambulatory setting has experienced some of the largest practice changes and advances. In this episode, we will explore how two ambulatory pharmacy leaders have navigated practice changes during this pandemic.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Friday Feb 05, 2021
Friday Feb 05, 2021
This podcast will describe important considerations for health systems of varying size regarding the handling and distribution process of the COVID-19 vaccine. The listeners of this podcast, organized by the Section of Pharmacy Practice Leaders Advisory Group on Strategy & Industry Disruptors, will hear from three different health systems on their lessons learned regarding the allocation of the COVID19 vaccine.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Thursday Feb 04, 2021
Thursday Feb 04, 2021
In this podcast, Vicki Basalyga, ASHP Director of Clinical Specialists and Scientists, chats with team members from AMA and ASHP about the upcoming six-week summit and the combined efforts by both organizations to advance pharmacogenomics in the healthcare field.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.